Kolltan Pharmaceuticals Secures $60,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=552daa84-247b-4506-ba59-01e7c6f9e298
Date
3/20/2014
Company Name
Kolltan Pharmaceuticals
Mailing Address
300 George St. New Haven, CT 06511 USA
Company Description
Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need.
Website
http://www.kolltan.com
Transaction Type
Venture Equity
Transaction Amount
$60,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed